Sljedeći

Auto Play

Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma

1 Pogledi • 08/09/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play